Short and intermediate-term effects of laparoscopic single anastomosis sleeve-jejunal bypass on type 2 diabetic morbidly obese patients. | ||
| The Egyptian Journal of Surgery | ||
| Volume 43, Issue 4, October 2024, Pages 1351-1357 PDF (300.54 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/EJSUR.2024.287279.1064 | ||
| Authors | ||
| Ahmed K. Gohar* ; Tharwat S. Kandil; Helmy Ezzat; Mahmoud A. Ali | ||
| Department of General Surgery, Gastrointestinal Surgical Center, Mansoura University, Dakahlia, Egypt | ||
| Abstract | ||
| Background: Obesity and its comorbidities are considered one of the major health tolls. Bariatric surgery offers significant and long-lasting weight loss as well as significant enhancements in glycemic management for severely obese individuals with type 2 diabetes mellitus. The single anastomosis sleeve jejunal (SASJ) bypass procedure is a novel form of bariatric surgery, it combines both malabsorptive and restrictive techniques. Aim: To evaluate the efficacy of laparoscopic SASJ bypass as a novel bariatric procedure for managing type 2 diabetes mellitus in morbidly obese patients during the first year following surgery. Patients and Methods: The current combined prospective and retrospective study was conducted at Mansoura University Gastrointestinal Surgical Center from December 2019 to January 2023. A total of 25 patients were included in the study. They were diagnosed clinically with primary morbid obesity with a body mass index (BMI) greater than 35 kg/m2 and documented type 2 diabetes mellitus All patients underwent laparoscopic SASJ procedure and were followed-up for 1 year after the operation. Results: The SASJ procedure was associated with significant weight loss outcomes, as the % excess weight loss (% EWL) was 26.29, 41.47, 53.33, and 67.52% at 3-, 6, 9-, 12-month follow-up visits, respectively, and % total weight loss (%TWL) values of 19.16, 30.16, 38.76, and 50.71% at the same intervals. Glycated hemoglobin, fasting blood sugar, and postprandial blood sugar showed a significant decrease at the scheduled follow-up visits compared with the baseline values. At 1-year follow-up, complete remission, partial remission, and improvement of diabetes were detected in 32, 40, and 28% of cases, respectively. Conclusion: The SASJ is a safe bariatric procedure that is associated with low morbidity rates. Besides excellent weight loss outcomes, it yields a beneficial impact on diabetes. | ||
| Keywords | ||
| Bariatric; bypass; diabetes mellitus; laparoscopy; single anastomosis sleeve jejunal | ||
|
Statistics Article View: 160 PDF Download: 142 |
||
